ZTS - Zoetis Inc - Ordinary Shares - Class A
Close
183.49
0.600 0.327%
Share volume: 2,328,499
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$182.89
0.60
0.33%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-14 | 2023-05-04 | 2023-08-08 | 2023-11-02 | 2024-02-13 | 2024-05-02 | |
| Assets | |||||||||
| Total Assets | 13.770 B | 13.674 B | 14.925 B | 13.754 B | 13.749 B | 14.106 B | 14.286 B | 14.348 B | |
| Current Assets | 6.651 B | 6.551 B | 7.506 B | 6.269 B | 6.183 B | 6.222 B | 6.343 B | 6.359 B | |
| Inventories | 2.205 B | 2.303 B | 2.345 B | 2.563 B | 2.701 B | 2.744 B | 2.564 B | 2.651 B | |
| Other Current Assets | 503.000 M | 552.000 M | 365.000 M | 411.000 M | 443.000 M | 467.000 M | 434.000 M | 440.000 M | |
| Short Term Investments | 503.000 M | 552.000 M | 365.000 M | 411.000 M | 443.000 M | 467.000 M | 434.000 M | 440.000 M | |
| Total Receivables | 1.291 B | 1.189 B | 1.215 B | 1.186 B | 1.322 B | 1.257 B | 1.304 B | 1.293 B | |
| Current Cash | 2.652 B | 2.507 B | 3.581 B | 2.109 B | 1.717 B | 1.754 B | 2.041 B | 1.975 B | |
| Total Non-current Assets | 7.119 B | 7.123 B | 7.419 B | 7.485 B | 7.566 B | 7.884 B | 7.943 B | 7.989 B | |
| Property Plant Equipment | 2.559 B | 2.623 B | 2.753 B | 2.913 B | 3.011 B | 3.092 B | 3.204 B | 3.251 B | |
| Other Assets | 147.000 M | 161.000 M | 147.000 M | 143.000 M | 173.000 M | 216.000 M | 206.000 M | 227.000 M | |
| Intangible Assets | 1.390 B | 1.319 B | 1.380 B | 1.314 B | 1.252 B | 1.398 B | 1.338 B | 1.295 B | |
| Goodwill | 2.720 B | 2.692 B | 2.746 B | 2.738 B | 2.714 B | 2.762 B | 2.759 B | 2.759 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 13.770 B | 13.674 B | 14.925 B | 13.754 B | 13.749 B | 14.106 B | 14.286 B | 14.348 B | |
| Total liabilities | 9.190 B | 9.011 B | 10.520 B | 9.260 B | 9.124 B | 9.028 B | 9.289 B | 9.290 B | |
| Total current liabilities | 3.051 B | 2.880 B | 3.167 B | 1.915 B | 1.769 B | 1.608 B | 1.889 B | 1.909 B | |
| Accounts Payable | 430.000 M | 373.000 M | 405.000 M | 424.000 M | 464.000 M | 388.000 M | 411.000 M | 405.000 M | |
| Other liabilities | 483.000 M | 480.000 M | 475.000 M | 478.000 M | 495.000 M | 521.000 M | 508.000 M | 505.000 M | |
| Current long term debt | 1.352 B | 1.353 B | 1.352 B | 3.000 M | 2.000 M | 2.000 M | 3.000 M | 24.000 M | |
| Long term debt | 5.221 B | 5.210 B | 6.552 B | 6.559 B | 6.555 B | 6.552 B | 6.564 B | 6.562 B | |
| Other liabilities | 483.000 M | 480.000 M | 475.000 M | 478.000 M | 495.000 M | 521.000 M | 508.000 M | 505.000 M | |
| Minority interest | 0.000 | -1.000 M | -2.000 M | -3.000 M | -4.000 M | -4.000 M | -6.000 M | -6.000 M | |
| Total Shareholder equity | 4.580 B | 4.663 B | 4.405 B | 4.494 B | 4.625 B | 5.078 B | 4.997 B | 5.058 B | |
| Common stock | 470.000 M | 467.800 M | 465.564 M | 463.500 M | 461.900 M | 460.300 M | 458.988 M | 458.000 M | |
| Retained earnings | 8.004 B | 8.533 B | 8.668 B | 9.045 B | 9.543 B | 10.140 B | 10.295 B | 10.696 B |